Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.

Source:http://linkedlifedata.com/resource/pubmed/id/11867759

Proc. Natl. Acad. Sci. U.S.A. 2002 Mar 5 99 5 2948-53

Download in:

View as

Triples

General Info

PMID
11867759